Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Harenberg

Showing results (11-20 of 193) with videos related to

Pageof 20
Sort By:
Seminars in Thrombosis and Hemostasis|October 1, 1990
Pharmacology of low molecular weight heparinsJ Harenberg
Medicinal Research Reviews|January 22, 1998
Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexideJ Harenberg
Zeitschrift Fur Kardiologie|December 19, 1998
[Anticoagulation in patients with heart valve replacement in pregnancy]J Harenberg
Seminars in Hematology|October 31, 2000
Risk assessment of venous thromboembolism in medical patientsJ Harenberg
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Old and new risk factors for upper extremity deep venous thrombosis - a rebuttalJ Harenberg
Deutsche Medizinische Wochenschrift (1946)|August 29, 1980
[Dosage of urokinase in venous thrombosis of the lower extremities]R Zimmermann, J Harenberg
Thrombosis and Haemostasis|April 7, 1987
Antithrombotic action of hepatic triglyceride lipase--fact or fictionJ Harenberg, J Augustin
Thrombosis and Haemostasis|October 18, 1993
Considerations about the correct nomenclature of glycosaminoglycans (GAGs)R Malsch, J Harenberg
Der Internist|May 1, 2009
[New agents for the prevention of venous thromboembolism]J Harenberg, S Nitschmann
Hamostaseologie|November 5, 2004
[Heparin, thrombin and Factor Xa inhibitors]J Harenberg, T Fenyvesi
Pageof 20

Showing results (11-20 of 193) with videos related to

Sort By:
Pageof 20
Seminars in Thrombosis and Hemostasis|October 1, 1990
Pharmacology of low molecular weight heparinsJ Harenberg
Medicinal Research Reviews|January 22, 1998
Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexideJ Harenberg
Zeitschrift Fur Kardiologie|December 19, 1998
[Anticoagulation in patients with heart valve replacement in pregnancy]J Harenberg
Seminars in Hematology|October 31, 2000
Risk assessment of venous thromboembolism in medical patientsJ Harenberg
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Old and new risk factors for upper extremity deep venous thrombosis - a rebuttalJ Harenberg
Deutsche Medizinische Wochenschrift (1946)|August 29, 1980
[Dosage of urokinase in venous thrombosis of the lower extremities]R Zimmermann, J Harenberg
Thrombosis and Haemostasis|April 7, 1987
Antithrombotic action of hepatic triglyceride lipase--fact or fictionJ Harenberg, J Augustin
Thrombosis and Haemostasis|October 18, 1993
Considerations about the correct nomenclature of glycosaminoglycans (GAGs)R Malsch, J Harenberg
Der Internist|May 1, 2009
[New agents for the prevention of venous thromboembolism]J Harenberg, S Nitschmann
Hamostaseologie|November 5, 2004
[Heparin, thrombin and Factor Xa inhibitors]J Harenberg, T Fenyvesi
Pageof 20